Myeloid neoplasms with eosinophilia
A Reiter, J Gotlib - Blood, The Journal of the American Society …, 2017 - ashpublications.org
Molecular diagnostics has generated substantial dividends in dissecting the genetic basis of
myeloid neoplasms with eosinophilia. The family of diseases generated by dysregulated …
myeloid neoplasms with eosinophilia. The family of diseases generated by dysregulated …
JAK/STAT signaling in hematological malignancies
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is
central to signaling by cytokine receptors, a superfamily of more than 30 transmembrane …
central to signaling by cytokine receptors, a superfamily of more than 30 transmembrane …
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Background Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are
clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of …
clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of …
[HTML][HTML] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with
myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors. An …
myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors. An …
Biology and significance of the JAK/STAT signalling pathways
H Kiu, SE Nicholson - Growth factors, 2012 - Taylor & Francis
Since its discovery two decades ago, the activation of the Janus kinase/signal transducers
and activators of transcription (JAK/STAT) pathway by numerous cytokines and growth …
and activators of transcription (JAK/STAT) pathway by numerous cytokines and growth …
STATs in oncogenesis
T Bowman, R Garcia, J Turkson, R Jove - Oncogene, 2000 - nature.com
Since their discovery as key mediators of cytokine signaling, considerable progress has
been made in defining the structure-function relationships of Signal Transducers and …
been made in defining the structure-function relationships of Signal Transducers and …
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
Background The V617F mutation, which causes the substitution of phenylalanine for valine
at position 617 of the Janus kinase (JAK) 2 gene (JAK2), is often present in patients with …
at position 617 of the Janus kinase (JAK) 2 gene (JAK2), is often present in patients with …
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
E Weisberg, PW Manley, W Breitenstein, J Brüggen… - Cancer cell, 2005 - cell.com
Summary The Bcr-Abl tyrosine kinase oncogene causes chronic myelogenous leukemia
(CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) …
(CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) …
A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
Background Idiopathic hypereosinophilic syndrome involves a prolonged state of
eosinophilia associated with organ dysfunction. It is of unknown cause. Recent reports of …
eosinophilia associated with organ dysfunction. It is of unknown cause. Recent reports of …
Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells
The reduction of iron is an essential step in the transferrin (Tf) cycle, which is the dominant
pathway for iron uptake by red blood cell precursors. A deficiency in iron acquisition by red …
pathway for iron uptake by red blood cell precursors. A deficiency in iron acquisition by red …